Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction

Laboratory Investigation

Volumn 83, Issue 8, 2003, Pages 1233-1240

  Nieuwenhuis, Eline J C ^a   Leemans, C René ^a   Kummer, Alain ^a   Denkers, Fedor ^a   Snow, Gordon B ^a   Brakenhoff, Ruud H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

E48 ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; HEAD AND NECK CANCER; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; NECK DISSECTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ANTIGENS, LY; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; DNA PRIMERS; DNA PROBES; GLYCOPROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NECK DISSECTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL RATE;

EID: 0041970257     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000083532.46536.56     Document Type: Article

References (27)

1. Bostick PJ, Morton DL, Turner RR, Huynh KT, Wang HJ, Elashoff R, Essner R, and Hoon DS (1999). Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 17:3238-3244.
2. Brakenhoff RH, Stroomer JG, Ten Brink CBM, De Bree R, Weima SM, Snow GB, and van Dongen GAMS (1999). Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction. Clin Cancer Res 5:725-732.
3. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, and Sidransky D (1995). Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332:429-435.
4. Cortesina G, Martone T, Galeazzi E, Olivero M, De Stefani A, Bussi M, Valente G, Comoglio PM, and Di Renzo MF (2000). Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int J Cancer 89:286-292.
5. Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Gusterson B, and Neville AM (1999). Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 354:896-900.
6. Gath HJ and Brakenhoff RH (1999). Minimal residual disease in head and neck cancer. Cancer Metastasis Rev 18:109-126.
7. Glickman JN, Torres C, Wang HH, Turner JR, Shahsafaei A, Richards WG, Sugarbaker DJ, and Odze RD (1999). The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 85:769-778.
8. Hosch S, Kraus J, Scheunemann P, Izbicky JR, Schneider C, Schumacher U, Witter K, Speicher MR, and Pantel K (2000). Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer. Cancer Res 60:6836-6840.
9. Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, Passlick B, Broelsch CE, and Pantel K (1997). Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 337:1188-1194,
10. Jones AS, Roland NJ, Field JK, and Phillips DE (1994). The level of cervical lymph node metastases: Their prognostic relevance and relationship with head and neck squamous carcinoma primary sites. Clin Otolaryngol 19:63-69.
11. Kano M, Shimada Y, Kaganoi J, Sakurai T, Li Z, Sato F, Watanabe G, and Imamura M (2000). Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA. Br J Cancer 82:429-435.
12. Leemans CR, Tiwari R, Nauta JJ, Van der Waal I, and Snow GB (1993). Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 71:452-456.
13. Leemans CR, Tiwari R, Van der Waal I, Karim AB, Nauta JJ, and Snow GB (1990). The efficacy of comprehensive neck dissection with or without postoperative radiotherapy in nodal metastases of squamous cell carcinoma of the upper respiratory and digestive tracts. Laryngoscope 100:1194-1198.
14. Liefers GJ, Cleton-Jansen AM, Van de Velde CJ, Hermans J, Van Krieken JH, Cornelisse CJ, and Tollenaar RA (1998). Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339:223-228.
15. McDonald LA, Walker DM, and Gibbins JR (1998). Cervical lymph node involvement in head and neck cancer detectable as expression of a spliced transcript of type II keratin K5. Oral Oncol 34:276-283.
16. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, and Wright RG (1996). Occult axillary node metastases in breast cancer: Their detection and prognostic significance. Br J Cancer 73:88-95.
17. Muir C and Weiland L (1995). Upper aerodigestive tract cancers. Cancer 75:147-153.
18. Nieuwenhuis EJC, Jaspars LH, Castelijns JA, Bakker B, Wishaupt RGA, Denkers F, Leemans CR, Snow GB, and Brakenhoff RH (2003). Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates. Clin Cancer Res 9:755-761.
19. Pantel K, Cote RJ, and Fodstad R (1999). Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91:1113-1124.
20. Pantel K (1996). Detection of minimal disease in patients with solid tumors. J Hematother 5:359-367.
21. Quak JJ, Balm AJM, van Dongen GAMS, Brakkee JGP, Scheper RJ, Snow GB, and Meijer CJLM (1990). A 22-kd surface antigen detected by monoclonal antibody E48 is exclusively expressed in stratified squamous and transitional epithelia. Am J Pathol 136:191-197.
22. Shah JP (1990). Cervical lymph node metastases: Diagnostic, therapeutic, and prognostic implications. Oncology 4:61-69.
23. Snow GB, Annyas AA, van Slooten EA, Bartelink H, and Hart AA (1982). Prognostic factors of neck node metastasis. Clin Otolaryngol 7:185-192.
24. Specht K, Richter T, Muller U, Walch A, Werner M, and Hofler H (2001). Quantitative gene expression analysis in microdis-sected archival formalin-fixed and paraffin-embedded tissue. Am J Pathol 158:419-429.
25. Stell PM, Morton RP, and Singh SD (1983). Cervical lymph node metastases: The significance of the level of the lymph node. Clin Oncol 9:101-107.
26. Van den Brekel MWM, Van der Waal I, Meijer CJLM, Freeman JL, Castelijns JA, and Snow GB (1996). The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 106:987-991.
27. Van Houten VMM, Tabor MP, Van den Brekel MWM, Denkers F, Wishaupt RG, Kummer JA, Snow GB, and Brakenhoff RH (2000). Molecular assays for the diagnosis of minimal residual head-and-neck cancer: Methods, reliability, pitfalls, and solutions. Clin Cancer Res 6:3803-3816.